Lidmed Lenalidomide Capsule 25mg

Product Description

Lidmed Lenalidomide 25 mg Capsule is a medication primarily used to treat certain types of cancer and conditions related to blood cell production. It belongs to a class of drugs known as immunomodulatory agents. Lenalidomide is similar to thalidomide, a drug used for conditions such as multiple myeloma, and has various effects on the immune system and blood cells.

Common uses:

• Multiple myeloma: Lenalidomide is used as part of a combination chemotherapy regimen to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.
• Myelodysplastic syndromes (MDS): It is used in cases of MDS with deletion of chromosome 5q (a specific genetic abnormality).
• Mantle cell lymphoma: Lenalidomide is also used in some cases of mantle cell lymphoma, a type of non-Hodgkin lymphoma.

How it works:

Lenalidomide works by affecting the immune system and disrupting the growth of cancer cells. It has several mechanisms of action, including:

• Enhancing immune response: It stimulates immune cells to attack and kill cancer cells.
• Inhibiting blood vessel growth: Lenalidomide can interfere with the formation of blood vessels that supply tumors, thus limiting tumor growth.
• Directly affecting cancer cells: It also inhibits the growth and survival of cancerous cells by affecting various signaling pathways.

Dosage and administration:

• The typical starting dose is 25 mg once a day, but the exact dosage depends on the condition being treated and other factors like your response to the medication.
• It is usually taken once daily with or without food.
• Capsules should be swallowed whole; they should not be opened, broken, or chewed.

Possible side effects:

• Low blood counts (hematologic side effects): Lenalidomide can cause low levels of white blood cells, red blood cells, and platelets, which increases the risk of infections, anemia, and bleeding. Regular blood tests are required to monitor these levels.
• Fatigue: Feeling tired or weak is common with this medication.
• Digestive issues: Nausea, diarrhea, constipation, or loss of appetite may occur.
• Rashes or skin reactions: Some people may experience skin rashes or itching.
• Blood clots: Lenalidomide can increase the risk of developing blood clots (deep vein thrombosis or pulmonary embolism), so your doctor may recommend blood thinners during treatment.
• Liver function: Liver enzymes should be monitored during treatment, as lenalidomide can cause liver issues in some patients.

Warnings and precautions:

• Pregnancy risk: Lenalidomide can cause severe birth defects or fetal death. It should never be used during pregnancy or by women who are breastfeeding. Women of childbearing age must use effective contraception during treatment and for some time after stopping the medication.
• Thrombosis risk: There is an increased risk of blood clots, especially in patients with multiple myeloma or those receiving lenalidomide in combination with other drugs. Your healthcare provider may prescribe anticoagulant medications to reduce this risk.
• Regular monitoring: You will need frequent blood tests and regular checkups to monitor your blood cell counts, liver function, and overall health during treatment.

Important considerations:

• Interaction with other medications: Always inform your doctor of any other medications you're taking, especially anticoagulants, other cancer treatments, or drugs that affect the immune system.
• Disposal: Lenalidomide is a hazardous drug, and special precautions should be taken when handling, administering, or disposing of the capsules.